Back
Sarepta Therapeutics Vs. B. Riley Financial Industry Stock Comparison
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
113.41
Seasonality Move:
2.77%
Buy
53
RILY
B. Riley Financial
Last Price:
28.50
Seasonality Move:
12.5%
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $123.46. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
B. Riley Financial (RILY)
is a Buy
Is B. Riley Financial a Buy, Sell or Hold?
- The current B. Riley Financial [RILY] share price is $30.70. The Score for RILY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- RILY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $123.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
RILY Stock Price Chart
What is B. Riley Financial's stock price today?
-
The B. Riley Financial share price today is $30.70
The current trend is moderately bearish and RILY is experiencing slight selling pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 36.02 | Sell |
Chaikin Money Flow: | -978649 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.58 - 134) | Sell |
Bollinger Bands (100): | (116.45 - 132.65) | Sell |
RILY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | -91292 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.68 - 35.12) | Sell |
Bollinger Bands (100): | (17.67 - 28.69) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.43 | Sell |
20-day SMA: | 130.9 | Sell |
50-day SMA: | 126.89 | Sell |
200-day SMA: | 114.09 | Buy |
8-day EMA: | 128.38 | Sell |
20-day EMA: | 129.07 | Sell |
50-day EMA: | 127.05 | Sell |
200-day EMA: | 118.7 | Buy |
RILY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.39 | Buy |
20-day SMA: | 32.03 | Sell |
50-day SMA: | 26.17 | Buy |
200-day SMA: | 29.34 | Buy |
8-day EMA: | 30.87 | Sell |
20-day EMA: | 30.46 | Buy |
50-day EMA: | 27.57 | Buy |
200-day EMA: | 28.73 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
B. Riley Financial Earnings Growth & RILY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
B. Riley Financial Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |